• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国新生儿筛查项目的最新质量调查与评估。

Up-to-date quality survey and evaluation of neonatal screening programs in China.

机构信息

National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing, China.

Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

BMC Pediatr. 2024 Jan 20;24(1):65. doi: 10.1186/s12887-024-04528-1.

DOI:10.1186/s12887-024-04528-1
PMID:38245686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10799474/
Abstract

AIMS

To thoroughly evaluate the quality of the entire process of neonatal screening (NBS) in China.

METHODS

We collected survey questionnaires from 54.4% (135/248) of NBS institutions in China and conducted on-site visits to 20 of these facilities to validate the data. The quality performance of the institutions was evaluated, and differences across various factors were analysed.

RESULTS

Merely 62.5% of the provinces had acceptable performance in neonatal screening. Institutions with limited staff were more prone to organizational management shortcomings. Institutions in provinces with a per capita GDP below 10,000 USD exhibited lower quality control levels than those with a per capita GDP between 10,000 and 15,000 USD. Obstetrics departments have a lower awareness of quality control compared to other blood collection facilities.

CONCLUSIONS

A nationwide, comprehensive quality control system for continuous enhancements in quality management, screening, diagnosis, and treatment is imperative to ensure prompt diagnosis and intervention.

摘要

目的

全面评估中国新生儿筛查(NBS)全过程的质量。

方法

我们收集了中国 54.4%(135/248)的 NBS 机构的调查问卷,并对其中 20 家机构进行了现场访问以验证数据。评估了机构的质量表现,并分析了不同因素之间的差异。

结果

仅有 62.5%的省份在新生儿筛查方面表现出可接受的性能。人员有限的机构更容易出现组织管理方面的缺陷。人均 GDP 低于 10000 美元的省份的机构比人均 GDP 在 10000 至 15000 美元之间的机构的质量控制水平更低。与其他采血机构相比,妇产科部门对质量控制的认识较低。

结论

需要建立一个全国性的、全面的质量控制系统,以不断加强质量管理、筛查、诊断和治疗,以确保及时诊断和干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b17/10799474/4eaa3d1f066f/12887_2024_4528_Figb_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b17/10799474/8718f5747496/12887_2024_4528_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b17/10799474/4eaa3d1f066f/12887_2024_4528_Figb_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b17/10799474/8718f5747496/12887_2024_4528_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b17/10799474/4eaa3d1f066f/12887_2024_4528_Figb_HTML.jpg

相似文献

1
Up-to-date quality survey and evaluation of neonatal screening programs in China.中国新生儿筛查项目的最新质量调查与评估。
BMC Pediatr. 2024 Jan 20;24(1):65. doi: 10.1186/s12887-024-04528-1.
2
Maternal and neonatal outcomes of elective induction of labor.择期引产的母婴结局
Evid Rep Technol Assess (Full Rep). 2009 Mar(176):1-257.
3
Epidural versus non-epidural or no analgesia for pain management in labour.硬膜外镇痛与非硬膜外镇痛或无镇痛用于分娩疼痛管理的比较。
Cochrane Database Syst Rev. 2018 May 21;5(5):CD000331. doi: 10.1002/14651858.CD000331.pub4.
4
Screening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health.孕前及孕期甲状腺功能障碍的筛查及后续管理,以改善母婴健康。
Cochrane Database Syst Rev. 2015 Sep 21;2015(9):CD011263. doi: 10.1002/14651858.CD011263.pub2.
5
Sexual Harassment and Prevention Training性骚扰与预防培训
6
Induction of labour for improving birth outcomes for women at or beyond term.引产以改善足月及过期妊娠女性的分娩结局。
Cochrane Database Syst Rev. 2018 May 9;5(5):CD004945. doi: 10.1002/14651858.CD004945.pub4.
7
Assessment and support during early labour for improving birth outcomes.分娩早期的评估与支持以改善分娩结局
Cochrane Database Syst Rev. 2017 Apr 20;4(4):CD011516. doi: 10.1002/14651858.CD011516.pub2.
8
Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes.对于疑似有胎儿窘迫的早产婴儿,立即分娩与延迟分娩以改善结局的比较。
Cochrane Database Syst Rev. 2016 Jul 12;7(7):CD008968. doi: 10.1002/14651858.CD008968.pub3.
9
Incentives for increasing prenatal care use by women in order to improve maternal and neonatal outcomes.为改善孕产妇和新生儿结局而激励女性增加产前检查的使用。
Cochrane Database Syst Rev. 2015 Dec 15;2015(12):CD009916. doi: 10.1002/14651858.CD009916.pub2.
10
Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).足月(37周及以上)胎膜早破时计划早产与期待治疗(等待)的比较。
Cochrane Database Syst Rev. 2017 Jan 4;1(1):CD005302. doi: 10.1002/14651858.CD005302.pub3.

引用本文的文献

1
Newborn screening for congenital hypothyroidism: worldwide coverage 50 years after its start.先天性甲状腺功能减退症的新生儿筛查:开展50年后的全球覆盖率
Eur Thyroid J. 2025 Jan 31;14(1). doi: 10.1530/ETJ-24-0327. Print 2025 Feb 1.
2
Parental awareness and perspectives on newborn screening in China: a questionnaire-based study.中国新生儿筛查的家长认知和观点:一项基于问卷的研究。
BMC Med Ethics. 2024 Nov 26;25(1):140. doi: 10.1186/s12910-024-01145-6.
3
Survey and analysis on the resource situation of primary health care institutions in rural China.

本文引用的文献

1
Is Our Newborn Screening Working Well? A Literature Review of Quality Requirements for Newborn Blood Spot Screening (NBS) Infrastructure and Procedures.我们的新生儿筛查工作进展顺利吗?新生儿血斑筛查(NBS)基础设施与程序质量要求的文献综述。
Int J Neonatal Screen. 2023 Jun 22;9(3):35. doi: 10.3390/ijns9030035.
2
Quality management of the newborn screening network: the Chinese experience.新生儿筛查网络的质量管理:中国经验
Chin Med J (Engl). 2023 Sep 5;136(17):2122-2124. doi: 10.1097/CM9.0000000000002386.
3
Guidelines for Newborn Screening of Congenital Hypothyroidism (2021 Revision).
中国农村基层医疗卫生机构资源状况调查分析。
Front Public Health. 2024 Jun 11;12:1394527. doi: 10.3389/fpubh.2024.1394527. eCollection 2024.
先天性甲状腺功能减退症新生儿筛查指南(2021年修订版)
Clin Pediatr Endocrinol. 2023;32(1):26-51. doi: 10.1297/cpe.2022-0063. Epub 2022 Dec 4.
4
Towards Achieving Equity and Innovation in Newborn Screening across Europe.迈向欧洲新生儿筛查的公平与创新。
Int J Neonatal Screen. 2022 May 6;8(2):31. doi: 10.3390/ijns8020031.
5
Newborn screening as a fully integrated system to stimulate equity in neonatal screening in Europe.新生儿筛查作为一个全面整合的系统,以促进欧洲新生儿筛查的公平性。
Lancet Reg Health Eur. 2022 Jan 28;13:100311. doi: 10.1016/j.lanepe.2022.100311. eCollection 2022 Feb.
6
Newborn screening system: Safety, technology, advocacy.新生儿筛查系统:安全性、技术、倡导。
Mol Genet Metab. 2021 Sep-Oct;134(1-2):3-7. doi: 10.1016/j.ymgme.2021.07.003. Epub 2021 Jul 16.
7
A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China.《柳叶刀》中国女性生殖、孕产妇、新生儿、儿童及青少年健康70年委员会
Lancet. 2021 Jun 26;397(10293):2497-2536. doi: 10.1016/S0140-6736(20)32708-2. Epub 2021 May 24.
8
Neonatal Screening for Congenital Metabolic and Endocrine Disorders–Results From Germany for the Years 2006–2018.新生儿先天性代谢和内分泌疾病筛查——2006-2018 年德国的结果。
Dtsch Arztebl Int. 2021 Feb 19;118(7):101-108. doi: 10.3238/arztebl.m2021.0009.
9
Newborn Screening: Still Room for Improvement.新生儿筛查:仍有改进空间。
Dtsch Arztebl Int. 2021 Feb 19;118(7):99-100. doi: 10.3238/arztebl.m2021.0008.
10
Improving quality management of newborn screening in southwest China.提高中国西南地区新生儿筛查的质量管理。
J Int Med Res. 2021 Apr;49(4):3000605211002999. doi: 10.1177/03000605211002999.